SCHEMBL9762101

SCHEMBL9762101

Cn1cnc(CN2OCCC2=O)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 1/20 0.41
TSHR P16473 1/20 0.41
CYP2C19 P33261 1/20 0.41
MTOR P42345 1/20 0.41
HRH4 Q9H3N8 1/20 0.41
HRH3 Q9Y5N1 1/20 0.41
TDP1 Q9NUW8 1/20 0.40
CHRM2 P08172 2/20 0.36
CHRM4 P08173 2/20 0.36
CHRM5 P08912 2/20 0.36
CHRM1 P11229 2/20 0.36
CHRM3 P20309 2/20 0.36
OGA O60502 1/20 0.32
ADRA2B P18089 1/20 0.32
ADRA2C P18825 1/20 0.32
SLC6A2 P23975 1/20 0.32
HTR1D P28221 1/20 0.32
HTR2C P28335 1/20 0.32
HTR2B P41595 1/20 0.32
NLRP3 Q96P20 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15055136 0.77 CYP2C9 (0.40) CYP2C9TSHRCYP2C19MTORHRH4
SCHEMBL9761111 0.75 CYP2C9 (0.38) CYP2C9TSHRCYP2C19MTORHRH4
SCHEMBL9760995 0.73 CHRM2 (0.36) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL9762225 0.72 PDE1A (0.37) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL9762460 0.71 RIPK3 (0.37) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL9762330 0.71 CHRM5 (0.43) CYP2C9CYP2C19CHRM2CHRM4CHRM5
SCHEMBL20692743 0.69 CYP2C9 (0.41) CYP2C9TSHRCYP2C19MTORHRH4
SCHEMBL9762399 0.68 BRD4 (0.35) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL21531725 0.67 CYP2C9 (0.50) CYP2C9TSHRCYP2C19MTORHRH4
SCHEMBL17525751 0.67 CYP2C9 (0.50) CYP2C9TSHRCYP2C19MTORHRH4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5066665-A Cognition activators; alzheimer*s disease WARNER-LAMBERT CO. (US) 1991-11-19 US claimed
US-5066665-A Cognition activators; alzheimer*s disease WARNER-LAMBERT CO. (US) 1991-11-19 US disclosed